Search
Innoviva Inc
INVAAdd to Watchlist
20.530USD
+0.290+1.43%
Market hours 09/24, 10:12（ET）
1.52BMarket Cap
2.82P/E TTM
Innoviva Inc (INVA) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Innoviva Inc in the past month.
Buy
2 Strong Buy
2 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
35.000USD+66.83%
INVA Analyst Recommendation Trends
In the current month, INVA has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. INVA average Analyst price target in the last month is 35.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
1
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
5
5
5
5
5
5
5
4
INVA Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, INVA EPS is projected to reach 0.515 in FY2026Q3, following reported EPS of -1.136 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.55
0.39
0.44
0.52
0.52
Actual
2.19
2.52
-1.14
--
--
Surprise
+298.60%
+545.16%
-360.59%
--
--
FAQs
What is Innoviva Inc's expected revenue for the next quarter?
Innoviva Inc's expected revenue is 115.30M.
What is Innoviva Inc's price target?
Analysts forecast that Innoviva Inc's price target is USD 35.00, with the highest forecast at USD 46.00 and the lowest forecast at USD 18.00.
How have Innoviva IncINVA's recent earnings per share performed?
The market expectation was USD -1.14, while Innoviva IncINVA's earnings per share (EPS) for the previous quarter was USD 2.52. EPS for the next quarter is expected at USD 0.52.
What is the analyst rating for Innoviva Inc?
Based on the ratings of Innoviva Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.